AP-2β inhibits hepatocellular carcinoma invasion and metastasis through Slug and Snail to suppress epithelial-mesenchymal transition.

AP-2β inhibits hepatocellular carcinoma invasion and metastasis through Slug and Snail to suppress epithelial-mesenchymal transition.
复制标题

AP-2β通过Slug和Snail抑制肝细胞癌侵袭和转移抑制上皮间质转化

DOI:
10.7150/thno.25166
复制
发表时间:
2018
期刊:
影响因子:
12.4
通讯作者:
Xiang S
Xiang S
中科院分区:
医学1区
文献类型:
--
作者:
Yang L;Qiu J;Xiao Y;Hu X;Liu Q;Chen L;Huang W;Li X;Li L;Zhang J;Ding X;Xiang S

文献摘要

参考文献

相似文献

Transcription factor AP-2β plays an important role in human cancer, but its clinical significance in hepatocellular carcinogenesis is largely unknown. Methods: AP-2β expression was detected in human hepatocellular cancer (HCC) tissues and cell lines. The effects of AP-2β on HCC proliferation, migration, invasion, tumor formation and metastasis were evaluated by MTT, colony formation and transwell assays in vitro and mouse experiments in vivo. The association between AP-2β and miR-27a/EMT markers in HCC cell lines and tissues was analyzed. Results: AP-2β expression was decreased in HCC tissues and cell lines. Reduced expression of AP-2β was significantly associated with more advanced tumor stages and larger tumor sizes. The overexpression of AP-2β reduced HCC proliferation, migration, invasion, tumor formation and metastasis in vitro and in vivo. Additionally, AP-2β overexpression increased the sensitivity of HCC cells to cisplatin. Moreover, AP-2β modulates the levels of EMT markers through Slug and Snail in HCC cell lines and tissues. Furthermore, oncogenic miR-27a inhibits AP-2β expression by binding to the AP-2β 3′ untranslated region (UTR) and reverses the tumor suppressive role of AP-2β. Conclusion: These results suggested that AP-2β is lowly expressed in HCC by inhibiting EMT signaling to regulate HCC cell growth and migration. Therefore, AP-2β in the novel miR-27a/AP-2β/Slug/EMT regulatory axis enhances the chemotherapeutic drug sensitivity of HCC and might represent a potential target for evaluating the treatment and prognosis of human HCC.
DOI: 10.1371/journal.pone.0099697
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者:
Li X;Jiang J;Shi S;Bligh SW;Li Y;Jiang Y;Huang D;Ke Y;Wang S
通讯作者: Wang S
DOI: 10.1007/s001090100211
发表时间: 2001-06-01
影响因子: 4.7
作者:
Beger, M;Butz, K;Hoppe-Seyler, F
通讯作者: Hoppe-Seyler, F
DOI: 10.1056/nejmoa0708857
发表时间: 2008-07-24
影响因子: 158.5
作者:
Llovet, Josep M.;Ricci, Sergio;Bruix, Jordi
通讯作者: Bruix, Jordi
DOI: 10.1038/ijo.2009.295
发表时间: 2010-04-01
影响因子: 4.9
作者:
Fuke, T.;Yoshizaki, T.;Maegawa, H.
通讯作者: Maegawa, H.
DOI: 10.1093/hmg/6.11.1817
发表时间: 1997-10-01
影响因子: 3.5
作者:
Fischer, U;Heckel, D;Meese, E
通讯作者: Meese, E